Further restrictions may be established through quantity limits, imposing constraints on the dosage and duration of usage
the table below summarizes some interesting ones - Screenshot 2025-08-18 at 7.33.39 PM8351004 99 KB Developments in Indian GLP-1 market Sun Pharma - Utreglutide (GL0034) (injectable, GLP-1 RA) Utreglutide is a novel, long-acting GLP-1 receptor agonist being developed by Sun Pharma
Whether you are dealing with rheumatoid arthritis (RA), psoriatic arthritis (PsA), lupus (SLE), Sjgrens disease (SD), or even osteoarthritis (OA), chronic inflammation keeps the immune system in a constant attack mode, leading to: Pain Swelling Stiffness Mobility problems Tissue and cartilage damage This chronic, ongoing inflammation not only makes joints hurt more, but it will worsen blood sugar control, fatigue, brain fog, and increase the risk of heart disease
What GLP-1 Gene Therapy Actually Is Think of it like this
Once your dose is optimized, we help you transition into a steady rhythm that supports stability, confidence, and sustainable progress